TITLE

Requirements for Use of a New International Certificate

PUB. DATE
February 2008
SOURCE
Travel Medicine Advisor;Feb2008, Vol. 18 Issue 2, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the new International Certificate of Vaccination or Prophylaxis (ICVP). ICVP provides space for potential certification of additional types of vaccination or prophylaxis to protect against newly emerging or reemerging diseases or other events of public health importance. It mentions a requirement for yellow fever vaccination to be indicated on the ICVP. It cites the availability of the certificates through the U.S. Government Printing Office (GPO).
ACCESSION #
30001712

 

Related Articles

  • Requirements for Use of a New International Certificate of Vaccination or Prophylaxis for Yellow Fever Vaccine.  // Clinical Infectious Diseases;3/1/2008, Vol. 46 Issue 5, piii 

    The article reports on the launch of new International Certificate of Vaccination or Prophylaxis (ICVP) in response to the 2005 revision of the International Health Regulations (IHR 2005) in the U.S. Accordingly, the new space for potential certification of additional types of vaccination or...

  • Requirements for Use of a New International Certificate of Vaccination or Prophylaxis for Yellow Fever Vaccine.  // MMWR: Morbidity & Mortality Weekly Report;2008, Vol. 56 Issue 51/52, p1345 

    The article discusses the requirements for using the International Certificate of Vaccination or Prophylaxis (ICVP) for yellow fever vaccine in the U.S. ICVP offers an opportunity to add other types of vaccination or prophylaxis for the prevention of newly emerging or reemerging diseases. The...

  • Yellow fever vaccine goes missing.  // Telegraph (Calcutta, India);7/9/2013, p1 

    The article reports on the lack of yellow fever vaccine in Calcutta, India. Topics discussed include the closure of the Central Research Institute in Himachal Pradesh which is the only yellow fever vaccine manufacturing unit in the country due to machine failure, the impact of the lack of the...

  • Yellow Fever.  // Immunization Newsletter;Aug2013, Vol. 35 Issue 4, p5 

    The article presents information on yellow fever, which is a major public health problem in the U.S. and neighbouring countries. Since 2007, the nations have experienced intense circulation of the yellow fever virus. The yellow fever vaccination strategies used in the nations include...

  • Does restricted distribution limit access and coverage of yellow fever vaccine in the United States? Monath, Thomas P.; Giesberg, Judith A.; Garcia Fierros, Edward Garcia // Emerging Infectious Diseases;Oct-Dec98, Vol. 4 Issue 4, p698 

    Opinion. Discusses the factors behind the limited access to and coverage of yellow fever vaccine in the United States. Association of an upsurge in yellow fever activity with an increased risk for infection among unimmunized travelers; Registration of yellow fever vaccinating centers in the...

  • Adverse Events Associated with 17D-Derived Yellow Fever Vaccination--United States, 2001-2002.  // MMWR: Morbidity & Mortality Weekly Report;11/8/2002, Vol. 51 Issue 44, p989 

    Summarizes preliminary findings on cases of yellow fever vaccine-associated viscerotropic disease in recipients of 17D-derived yellow fever vaccine (YEL) in the U.S. from 2001 to 2002. Number of reports of adverse events following YEL administration during June 20, 2001 to August 31, 2002;...

  • Prevention of Yellow Fever in Persons Traveling to the Tropics. Monath, Thomas P.; Cetron, Martin S. // Clinical Infectious Diseases;5/15/2002, Vol. 34 Issue 10, p1369 

    Presents a study of the preventive vaccine for yellow fever (YF) in persons traveling to the tropics. Risk factors of YF during travel; Use of YF 17D vaccine to prevent the disease; Tips on avoiding unnecessary vaccination.

  • Yellow Fever Initiative. Stephenson, Joan // JAMA: Journal of the American Medical Association;6/20/2007, Vol. 297 Issue 23, p2578 

    This article reports on the Yellow Fever Initiative from the World Health Organization. Funded by the Global Alliance for Vaccines and Immunization, the program will set up comprehensive immunization campaigns in a dozen West African countries such as Benin, Burkina Faso, Cameroon, Ghana. The...

  • Antibody response to 17D yellow fever vaccine in Ghanaian infants. Osei-Kwasi, Mubarak; Dunyo, S.K.; Koram, K.A.; Afari, E.A.; Odoom, J.K.; Nkrumah, F.K. // Bulletin of the World Health Organization;2001, Vol. 79 Issue 11, p1056 

    Assesses the seroresponses to yellow fever vaccination in Ghana. Immunization of infants; Immunogenicity of AIK-C measles vaccine; Implication on the absence of antibodies.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics